financetom
Business
financetom
/
Business
/
Bionano Genomics Says Revvity to Commercialize VIA Software
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bionano Genomics Says Revvity to Commercialize VIA Software
Jun 20, 2024 7:53 AM

10:22 AM EDT, 06/20/2024 (MT Newswires) -- Bionano Genomics ( BNGO ) said Thursday it has signed a software marketing agreement with Revvity ( RVTY ) to market and commercialize VIA software.

Financial details of the agreement weren't disclosed.

Bionano said its VIA software will be marketed as part of Revvity's ( RVTY ) newborn sequencing research workflow and is expected to improve Revvity's ( RVTY ) newborn sequencing solution by integrating copy number variation assessment into the next generation sequencing report and enhancing workflow interpretation capabilities.

Price: 0.80, Change: +0.02, Percent Change: +3.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved